Oral Drug for Brain Tumor Could Change Treatment Landscape
In patients with gliomas bearing IDH1/2 mutations, the brain barrier-crossing oral drug vorasidenib kept tumors at bay, and could be used instead of more toxic chemotherapies and radiation.
Medscape Medical News
source https://www.medscape.com/viewarticle/992745?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992745?src=rss
Comments
Post a Comment